To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/intensity-modulated-radiotherapy-market
The increasing prevalence of different cancers such as prostate, breast cancer lung cancer, and other is driving the demand for Intensity-modulated radiotherapy (IMRT). According to the National Institute of Health (NIH), in March 2023, Global Cancer Observatory (GLOBOCAN) estimated, there were 19.3 million incident cancer cases globally for the year 2020. India ranked third after China and the US. GLOBOCAN predicted that cancer cases in India would increase to 2.08 million, accounting for a rise of 57.5% in 2040 from 20202.
The new radiopaque version can be seen on computerized tomography (CT) scans, negating the need for physicians to include magnetic resonance imaging (MRI) in the treatment planning, and accommodating patients who are contra-indicated for MRI. For instance, in October 2022, Royal Philips, in health technology, launched two new advances in MR-only workflows to advance head and neck cancer radiotherapy imaging and simulation. Treatment of soft tissue tumors in the head and neck, along with the brain, pelvis, and prostate, has received FDA 510(k) clearance and is commercially available in the US.
Market Coverage
- The market number available for – 2022-2030
- Base year- 2022
- Forecast period- 2023-2030
- Segment Covered-
o By Radiation Type
o By Application
o By End Users
- Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
- Competitive Landscape- Hitachi, Ltd., Koninklijke Philips N.V., Siemens Healthineers AG., Accuray, Inc., Hitachi, Ltd., Mevion Medical Systems., Sumitomo Heavy Industries, Ltd., and Varian Medical Systems, Inc.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- Who is the leader in the market?
- How are players addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Intensity Modulated Radiotherapy Market Report Segment
By Radiation Type
- Photon Radiation
- Electron Beam Radiation
- Proton Radiation
- Carbon ion Radiation
By Application
- Prostate Cancer
- Breast Cancer
- Lung Cancer
- Gastrointestinal Cancer
- Other Cancer
By End Users
- Hospitals
- Specialty Center
A full report of Intensity Modulated Radiotherapy Market available @ https://www.omrglobal.com/industry-reports/intensity-modulated-radiotherapy-market
Company Profiles
- Accuray, Inc.
- Brainlab AG
- DOSIsoft SA
- IBA Proton Therapy
- Ion Beam Applications S.A.
- Leo Cancer Care
- Mevion Medical Systems.
- ProTom International
- RaySearch Laboratories
- Sumitomo Heavy Industries, Ltd.
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404
Company Name: Orion Market Research